Dr. Benjamin Bitler of the University of Colorado is a 2022 recipient of OCRA’s Collaborative Research Development Grant. His OCRA-funded project, which is expanding on findings from the Ovarian Cancer Research … Continued
In a profile with Westfair Business Journal, OCRA’s President & CEO Audra Moran speaks about her background, the direction of ovarian cancer research and prevention, and how OCRA’s programs are … Continued
September is the official month for Ovarian Cancer Awareness. Ovarian Cancer Awareness Month is our time to spread the word about risk and prevention, rally for more scientific research, and … Continued
No, a Pap smear does not test for ovarian cancer; it screens for cervical cancer. In fact, no reliable screening or early detection tests exist for ovarian cancer. What is … Continued
OCRA-Funded Study Targets Immunotherapy OCRA grantees and their Roswell Park Comprehensive Cancer Center colleagues published results from an exciting study detailing a new approach to adoptive T-cell therapy that may help improve immunotherapy … Continued
A recent study from Cancer Nursing has shed more light on the profound impact gynecologic cancer has on survivors, even after treatment. In particular, the study highlighted the prevalence of … Continued
Dr. Chi Lam Au Yeung of the University of Texas MD Anderson Cancer Center is a 2022 recipient of OCRA’s Early Career Investigator Grant. Her OCRA-funded project is focused on … Continued
Two groups of golf aficionados are stirring up some playful competition this summer to raise funds for a serious cause: ovarian cancer research. And though their charity tournaments are separate … Continued
Fewer people each year are being diagnosed with ovarian cancer. Why do you feel the numbers are decreasing? OCRA’s Scientific Advisory Committee (SAC) is composed of doctors and researchers who … Continued
TODAY show contributor Jill Martin opened up about her recent breast cancer diagnosis, and urged viewers to speak with their doctors to see if genetic testing is warranted. Says Martin, … Continued
Snap summary: OCRA-funded researchers set out to improve immune response against a known therapeutic target, and provided a glimpse into a world where an ovarian cancer patient’s own immune system … Continued
Janice Paulshock first began connecting with others in the ovarian cancer community in 1999 after being diagnosed with Stage 3C high-grade serous carcinoma. Twenty-plus years and four recurrences later, she … Continued
Get email updates about research news, action alerts, and ways to join the fight.
